semaglutide cascade Receives FDA Approval for Treatment of MASH Semaglutide GLP-1 Receptor Agonist Research

Please note: While some medications available through Gala GLP-1 are FDA-approved for weight management, compounded medications are not reviewed or approved by the FDA

A RECENT study has identified a potential link between the use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), and an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes (T2D) or those who are overweight or obese

Using Truveta Data, we sought to answer a few simple but timely questions: who is receiving the oral semaglutide pill in the first weeks following FDA approval, what provider types are prescribing these drugs, and are these patients new GLP-1-therapy initiators or patients switching from an existing prescription

Ozempic is a once-weekly injectable medication used to help regulate blood sugar levels in people with Type 2 diabetes

Prolonged Release: Microencapsulated R-lipoic acid can be formulated for sustained release, providing a steady supply of the active ingredient over time

Final thoughts If youre reading this because youre considering GLP-1 therapy, or already using it and want a more comprehensive approach, here are key take-aways: GLP-1s can be powerful tools for glycemic control and weight/metabolic healthbut they carry side-effects and nutrient risks